Adjustable Coronary Sinus Occlusion Balloon Catheter
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing vascular occlusion devices for the coronary sinus lack the ability to provide fully adjustable and controlled occlusion, which limits their effectiveness in managing myocardial infarction and redistributing blood flow.
Innovation Solution
The development of a vascular pressure monitoring system with a catheter body featuring inflatable balloons and pressure sensors, allowing for variable flow restriction and retrograde drug infusion within the coronary sinus.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If a balloon catheter is used for coronary sinus occlusion, then flow redistribution is improved, but the device lacks adjustable flow restriction capability
Solution Approach 1:
The patent applies dynamics by making the occlusion device adjustable rather than fixed. The balloon catheter incorporates pressure sensors and control systems that allow the occlusion level to be dynamically modified during the procedure, enabling the device to adapt to different physiological conditions and treatment requirements.
Solution Approach 2:
The patent changes physical parameters by introducing pressure sensors that monitor vascular pressure and allow adjustment of the occlusion degree. By modifying pressure parameters and flow restriction levels, the system achieves adaptable flow control while maintaining a relatively simple catheter structure through parameter-based control rather than mechanical complexity.
2Extent of automation
If intermittent occlusion is implemented to improve retrograde perfusion, then myocardial salvage is enhanced, but precise control of occlusion timing and duration is limited
Solution Approach 1:
The patent implements feedback control by incorporating pressure sensors that continuously monitor vascular pressure during occlusion. The system uses this feedback information to automatically adjust occlusion timing and duration, enabling precise control of the intermittent occlusion protocol and optimizing myocardial salvage while minimizing treatment time.
Solution Approach 2:
The patent replaces manual mechanical control with automated electronic control systems. Pressure sensors and electronic control circuits substitute for manual timing mechanisms, providing automated and precise control of occlusion timing and duration, thereby reducing operator error and optimizing treatment protocols.
3Measurement precision
If pressure sensors are added to enable variable flow restriction, then flow control precision is improved, but device complexity increases
Solution Approach 1:
The patent applies universality by designing pressure sensors that serve multiple functions: they measure pressure for feedback control, guide occlusion timing, and monitor treatment efficacy. This multi-functionality justifies the addition of sensors while minimizing overall system complexity, as the same sensing elements perform multiple critical roles in the treatment protocol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system enables improved myocardial salvage and reperfusion by allowing for adjustable occlusion of the coronary sinus, thereby reducing infarct size and enhancing blood flow redistribution.
Implementation Method 1
at least one balloon communicating with the inflation lumen, distally disposed on the catheter body to define a vascular flow restriction when inflated within a vascular lumen
Implementation Method 2
Pressure sensors may include a distal pressure sensor disposed distally with respect to the balloon and a proximal pressure sensor disposed proximally with respect to the balloon
Data Source
AI summary
Systems, devices and methods of adjustable and controlled vascular occlusion of the coronary sinus and other vessels using catheter-mounted and implantable occlusion devices that facilitate retrograde drug infusion and pressure monitoring are disclosed. Disclosed systems, devices and methods include balloons and self-supporting adjustable flow restricting structures for improved retrograde perfusion after a myocardial infarct.


